Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/81856
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Targeting sodium/iodide symporter gene expression for estrogen-regulated imaging and therapy in breast cancer |
Autor: | Martín-Duque, Pilar; Vieja, Antonio de la CSIC ORCID; Quintanilla, Miguel CSIC ORCID; Vassaux, Georges; Lemoine, Nick R. | Fecha de publicación: | 2008 | Editor: | Nature Publishing Group | Citación: | Cancer Gene Therapy 15(7): 465-473 (2008) | Resumen: | Expression of the sodium iodide symporter (hNIS) has been detected in breast cancer tissue, but frequently, not at the levels necessary to mediate 131I accumulation. Transducing the hNIS gene into breast cancer cells with adenovirus could be a tractable strategy to render breast cancer susceptible to radioiodide therapy. We constructed the replication-incompetent virus, AdSERE, in which an estrogen-responsive promoter directs the expression of hNIS. In vitro, we demonstrate that AdSERE mediates hNIS expression and iodide uptake in ER+ breast cancer cells. In vivo, we show that AdSERE-infected ER+ tumors can be imaged due to tracer accumulation; in addition, AdSERE in combination with therapeutic doses of 131I suppresses tumor growth. © 2008 Nature Publishing Group All rights reserved. | URI: | http://hdl.handle.net/10261/81856 | DOI: | 10.1038/cgt.2008.6 | Identificadores: | doi: 10.1038/cgt.2008.6 issn: 0929-1903 e-issn: 1476-5500 |
Aparece en las colecciones: | (IIBM) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
accesoRestringido.pdf | 15,38 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
14
checked on 06-mar-2024
WEB OF SCIENCETM
Citations
14
checked on 22-feb-2024
Page view(s)
314
checked on 18-mar-2024
Download(s)
95
checked on 18-mar-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.